MADRIGAL PHARMACEUTICALS, INC. short interest in 2023
In 2023, MADRIGAL PHARMACEUTICALS, INC.'s disclosed short interest ran from 5.70% of shares outstanding on 13 Jan 2023 to 16.48% on 29 Dec 2023, a change of +10.78 percentage points. The year's high was 18.47% on 31 Oct 2023 and its low 5.51% on 15 Feb 2023, averaging 10.65% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 10.96 days on 29 Dec 2023. Full history: MADRIGAL PHARMACEUTICALS, INC..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 5.70% (13 Jan 2023)
- End of year
- 16.48% (29 Dec 2023)
- Change
- +10.78 pp
- High
- 18.47% (31 Oct 2023)
- Low
- 5.51% (15 Feb 2023)
- Average
- 10.65%
- Highest days to cover
- 10.96 (29 Dec 2023)
- SEC filings marked
- 8
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 5.70% | 2.30 | |
| 31 Jan 2023 | 5.52% | 3.06 | |
| 15 Feb 2023 | 5.51% | 2.88 | |
| 28 Feb 2023 | 6.02% | 1.90 | 10-K filed, results (8-K) |
| 15 Mar 2023 | 7.01% | 2.60 | |
| 31 Mar 2023 | 7.26% | 2.81 | |
| 14 Apr 2023 | 8.67% | 5.62 | |
| 28 Apr 2023 | 8.10% | 3.45 | |
| 15 May 2023 | 6.91% | 3.64 | 10-Q filed, results (8-K) |
| 31 May 2023 | 7.94% | 4.43 | |
| 15 Jun 2023 | 8.77% | 6.26 | |
| 30 Jun 2023 | 9.61% | 2.57 | |
| 14 Jul 2023 | 10.31% | 10.25 | |
| 31 Jul 2023 | 10.01% | 7.64 | |
| 15 Aug 2023 | 9.79% | 5.71 | 10-Q filed, results (8-K) |
| 31 Aug 2023 | 10.62% | 10.11 | |
| 15 Sep 2023 | 11.54% | 4.19 | |
| 29 Sep 2023 | 14.32% | 5.22 | |
| 13 Oct 2023 | 16.30% | 5.29 | |
| 31 Oct 2023 | 18.47% | 8.73 | |
| 15 Nov 2023 | 17.50% | 7.49 | 10-Q filed, results (8-K) |
| 30 Nov 2023 | 17.60% | 10.16 | |
| 15 Dec 2023 | 15.55% | 6.45 | |
| 29 Dec 2023 | 16.48% | 10.96 |
See also: MADRIGAL PHARMACEUTICALS, INC.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.